NovaPlex HPV28
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) intends to award a sole source purchase/delivery order to Seegene USA, Inc. for NovaPlex HPV28 Detection Laboratory Tests. This action is based on FAR Part 13.103-1 (SAP). This is not a request for competitive proposals.
Scope of Work
The contractor shall provide HPV28 laboratory tests.
Contract & Timeline
- Type: Sole Source Purchase/Delivery Order (Combined Synopsis/Solicitation)
- Awardee: Seegene USA, Inc.
- Authority: FAR Part 13.103-1 (SAP)
- Set-Aside: None (Sole Source)
- Published: March 5, 2026
- Response Due: March 15, 2026 (10 days from publication for interested firms)
Evaluation
This is a sole source procurement. Firms that believe they can provide the required services are encouraged to identify themselves and provide written notification. Information received will be considered solely for determining whether to conduct a competitive procurement. A determination by the Government not to compete is at its sole discretion.
Additional Notes
No solicitation is available. Inquiries may be sent to Phil Alexander via email at PALEXANDER@CDC.GOV or by facsimile at 770-488-2067.